Active

EXTRA-PHARMA

Switched

BE0467149426

Rechtspersoon Private limited company 1 establishment

Antwerpsesteenweg 188, 2950 Kapellen Detailhandel in farmaceutische producten

Active for

26 year, 10 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 765,107

▼ 15% vs 2024

Profit

Healthy

€ 97,780

▼ 76% vs 2024

Debts

Normal

€ 2.5 million

▼ 15% vs 2024

EXTRA-PHARMA from Kapellen, company number BE0467149426, closed financial year 2025 with a result of € 97,780 after tax. For that financial year EXTRA-PHARMA recorded a gross margin of € 765,107 and equity of € 559,094. Compared with financial year 2024, the result moved from € 413,070 to € 97,780. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.

What happened at EXTRA-PHARMA?

What happened at EXTRA-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 97,780 (▼ 76% vs 2024). Source: NBB ↗
  • Cavely BV became a director. NBB
  • Verluco NV stepped down as director. NBB
  • New establishment in Kapellen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 252,780 profit in 2022 to € 97,780 profit in 2025.

Paid € 176,857 in corporate taxes since 2022.

Best year ever: 2024, with € 413,070 profit.

On average € 87,900 of value added per employee in 2025.

A new publication or filing at EXTRA-PHARMA? We notify you, reason included.

Follow EXTRA-PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

EXTRA-PHARMA

Behind EXTRA-PHARMA is Cavely BV.

See the full network in the app

Directors

According to the 2025 annual accounts

Cavely BV

Director · represented by Carlijn Van den Eede

since 2024

Verluco NV

Director · represented by Luc Roger J Van den Eede

· until 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Antwerpsesteenweg 188

2950 Kapellen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0467.149.426
VAT number
BE 0467.149.426
Registered office
Antwerpsesteenweg 188, 2950 Kapellen
Names & denominations
EXTRA-PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
26 October 1999
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of EXTRA-PHARMA?
The enterprise number of EXTRA-PHARMA is BE0467149426.
What is the address of EXTRA-PHARMA?
The registered office of EXTRA-PHARMA is located at Antwerpsesteenweg 188, 2950 Kapellen.
When was EXTRA-PHARMA founded?
EXTRA-PHARMA was founded on 26 October 1999.
What is the main activity of EXTRA-PHARMA?
The main activity of EXTRA-PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does EXTRA-PHARMA have a website?
No website is currently known for EXTRA-PHARMA.
How much profit did EXTRA-PHARMA make in 2025?
EXTRA-PHARMA posted a profit after taxes of € 97,780 in financial year 2025.
What is the revenue of EXTRA-PHARMA?
As a small company, EXTRA-PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 765,107.
How many employees does EXTRA-PHARMA have?
According to the 2025 annual accounts, EXTRA-PHARMA has 8.7 full-time equivalents (FTE).
Where can I find the annual accounts of EXTRA-PHARMA?
EXTRA-PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of EXTRA-PHARMA?
According to the 2025 annual accounts, the directors of EXTRA-PHARMA are: Cavely BV, Verluco NV.
Who owns EXTRA-PHARMA?
Behind EXTRA-PHARMA is Cavely BV.